Pure Global
NCT06116981

High-induction Magnetic Field Therapy in Patients With Shoulder Pain

Effects of High-induction Magnetic Field Therapy in Patients With Shoulder Pain
KTO Karatay University·ClinicalTrials.gov·otherRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Rehabilitation
Drug/Device/Intervention
High Induction Magnetic Field Therapy
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
KTO Karatay University
Location
Konya, Turkey
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2023
End date
Dec 25, 2023
Enrollment
35 participants
Primary outcome

Visual analogue scale-VAS,Range of Motion,Disabilities of the Arm, Shoulder and Hand (DASH),Constant Murley Score

Summary

High Induction Magnetic Field Therapy is a therapeutic method that uses high-intensity fields
 (up to 2.5 T) that produce high current density in exposed tissue. While there are studies in
 the literature on devices with 2.5 T, there is no research on the effect of 4 T. Magnetic
 field application contributes significantly to the healing process. It is an easier, cheaper,
 and more comfortable application. The magnetic field has been clinically proven to be safe.
 It is a practical, non-invasive method to induce cell and tissue modifications, correcting
 selected pathological conditions through magnetic application. The aim of the study is to
 investigate whether High Induction Magnetic Field therapy applied in addition to conservative
 treatment in patients with shoulder pain makes a difference compared to conservative
 treatment alone.

ICD-10 classifications
Care involving use of rehabilitation proceduresDrug rehabilitationCare involving use of other rehabilitation proceduresCare involving use of rehabilitation procedure, unspecifiedPersonal history of rehabilitation measures
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06116981
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06116981 through Pure Global AI's free database. This phase not specified trial is sponsored by KTO Karatay University and is currently Recruiting. The study focuses on Rehabilitation. Target enrollment is 35 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.